絞り込み

16390

広告

「ranibizumab」の検索結果

3606件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study.

Photodynamic therapy in combination with Ranibizumab versus Ranibizumab monotherapy for polypoidal choroidal vasculopathy: A systematic review and meta-analysis.

The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro.

[Two-Year Follow-up Results of Patients with Macular Oedema Due to Retinal Vein Occlusion Treated with Ranibizumab].

Ranibizumab after laser photocoagulation failure in retinopathy of prematurity (ROP) treatment.

Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration.

An 8-year follow-up of anti-vascular endothelial growth factor treatment with a treat-and-extend modality for neovascular age-related macular degeneration.

Laser-Induced Choroidal Neovascularizations: Clinical Study of 3 Cases.

Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion.

Sickle cell retinopathy: improving care with a multidisciplinary approach.

Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections.

Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience.

3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy.

Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant.

A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patients with Wet Age-Related Macular Degeneration from Portugal.

Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study.

Effects of VEGF levels on anti-VEGF therapy for patients with idiopathic choroidal neovascularization.

Long-Term Outcomes of Two Different Initial Dosing Regimens of Intravitreal Ranibizumab Used to Treat Myopic Choroidal Neovascularization.

Book Review: Anti-VEGF Use in Ophthalmology.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります